Assertio Mergers and Acquisitions Summary

Life ScienceCompany

Assertio has acquired 3 companies, including 2 in the last 5 years. It has also divested 3 assets.

Assertio’s largest acquisition to date was in 2013, when it acquired Nautilus Neurosciences - CAMBIA® for $49M. It’s largest disclosed sale occurred in 2020, when it sold Assertio Therapeutics - NUCYNTA to Collegium Pharmaceutical for $375M. Assertio has acquired in 3 different US states. The Company’s most targeted sectors include life science (67%) and medical products (34%).

Join Mergr and gain access to Assertio’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity6
    • M&A Buy Activity3
    • M&A Sell Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 5
  • M&A Advisors 3

Assertio

Assertio Holdings, Inc.

100 South Saunders Road Suite 300,
Lake Forest, Illinois 60045
United States,
(224) 419-7106
www.assertiotx.com

Assertio is a pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions. Assertio was founded in 1995 and is based in Lake Forest, Illinois.


M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.4/yr) # 1 - - 1 1 - 3
vol $49M $44M $93M
Sell (0.4/yr) # 1 - - 2 - - 3
vol $503M $503M
  6

Most Recent M&A

Company Date Value Type
Otrexup 2021-12-15 44M USD Divestiture
, New Jersey · www.otrexup.com
Zyla Life Sciences 2020-03-16 - Merger
Wayne, Pennsylvania · www.zyla.com
Assertio Therapeutics, Inc. - NUCYNTA 2020-02-06 375M USD Divestiture
, California
Assertio Therapeutics, Inc. - Gralise Business 2020-01-13 128M USD Divestiture
Newark, California
Depomed - Diabetes Royalty Rights 2015-11-04 - Divestiture
, United States
Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution) 2013-12-17 49M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (67%) 44M (47%) 2 (67%) 503M (100%)
Medical Products 1 (33%) 49M (53%) 1 (33%) -
Total 3 $93M 3 $503M

By Geo

State/Country Buy Value Sell Value
United States 3 93M 3 503M
  California - - 2 503M
  Pennsylvania 1 - - -
  New Jersey 1 44M - -
Total 3 $93M 3 $503M

Top M&A Advisors

Financial Deals
Stifel, Nicolaus & Co., Inc.
2
Legal Deals
Gibson, Dunn & Crutcher LLP
2
Greenberg Traurig LLP
1

Deal Values

buy # Total
< $100M 2 $93M
TOTAL $93M
Largest Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution)
$49M (2013-12-17)
sell # Total
$100M to $1B 2 $503M
TOTAL $503M
Largest Assertio Therapeutics, Inc. - NUCYNTA
$375M (2020-02-06)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 178,166
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 168K M&A Transactions
  • 174K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.